The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predicting immunotherapy toxicity through single-cell sequencing of peripheral immune cells: A pilot study.
 
Jennifer Wen Ying Lim
No Relationships to Disclose
 
Venessa T. Chin
Honoraria - Boehringer Ingelheim
 
Patricia Keith
No Relationships to Disclose
 
Rachael McCloy
No Relationships to Disclose
 
Drew Neavin
No Relationships to Disclose
 
Angli Xue
No Relationships to Disclose
 
Dominik Kaczorowski
Employment - Roche (I)
 
Ellie Spenceley
No Relationships to Disclose
 
Himanshi Arora
No Relationships to Disclose
 
Anthony M. Joshua
Stock and Other Ownership Interests - Opthea; Pricilium Therapeutics
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Eisai (Inst); Grey Wolf Therapeutics (Inst); IDEAYA Biosciences (Inst); Ipsen (Inst); IQvia (Inst); Janssen Oncology (Inst); Medison (Inst); Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Starpharma (Inst)
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Janssen Oncology (Inst); Lilly (Inst); Lilly (Inst); Mayne Pharma (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Cancer therapeutic methods
 
Joseph Powell
No Relationships to Disclose